159870-89-0 Usage
Uses
Used in Dye and Pigment Production:
C6H2Cl2N2S is used as a chemical intermediate for the production of dyes and pigments, contributing to the coloration and stability of these products in various applications.
Used in Pharmaceutical Synthesis:
As a precursor, C6H2Cl2N2S is utilized in the synthesis of pharmaceuticals, playing a crucial role in the development of new drugs and medicinal compounds.
Used in Agrochemical Production:
C6H2Cl2N2S is employed as a pesticide, leveraging its antimicrobial properties to protect crops and enhance agricultural productivity.
Used in Industrial Chemical Synthesis:
C6H2Cl2N2S serves as an important intermediate in the synthesis of various industrial chemicals, contributing to the manufacturing processes across different industries.
Used in Rubber, Textile, and Plastics Manufacturing:
C6H2Cl2N2S is used in the production of rubber, textiles, and plastics, enhancing the properties and performance of these materials in their respective applications.
Check Digit Verification of cas no
The CAS Registry Mumber 159870-89-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,8,7 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 159870-89:
(8*1)+(7*5)+(6*9)+(5*8)+(4*7)+(3*0)+(2*8)+(1*9)=190
190 % 10 = 0
So 159870-89-0 is a valid CAS Registry Number.
159870-89-0Relevant academic research and scientific papers
BICYCLIC COMPOUNDS FOR DIAGNOSIS AND THERAPY
-
Page/Page column 93; 94, (2017/09/27)
The present invention relates to the compounds of formula (I) that can be employed in the diagnosis, monitoring of disease progression or monitoring of drug activity, of a group of disorders and abnormalities associated with alpha-synuclein (a-synuclein, A- synuciein, aSynuciein, A-syn, a-syn, aSyn) aggregates including, but not limited to, Lewy bodies and/or Lewy neurites, such as Parkinson's disease. The instant compounds are particularly useful in determining a predisposition to such a disorder, monitoring residual disorder, or predicting the responsiveness of a patient who is suffering from such a disorder to the treatment with a certain medicament. The present compounds can also be used to treat, alleviate or prevent a disorder or abnormality associated with alpha-synuclein aggregates.
